ifosfamide has been researched along with Sarcopenia in 2 studies
Sarcopenia: Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
Excerpt | Relevance | Reference |
---|---|---|
"Eighteen patients (35." | 1.48 | Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin. ( Armento, G; Badalamenti, G; Catania, G; Incorvaia, L; Maltese, G; Napolitano, A; Santini, D; Silletta, M; Spalato Ceruso, M; Tonini, G; Valeri, S; Vincenzi, B, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kiyotoki, T | 1 |
Nakamura, K | 1 |
Haraga, J | 1 |
Omichi, C | 1 |
Ida, N | 1 |
Saijo, M | 1 |
Nishida, T | 1 |
Kusumoto, T | 1 |
Masuyama, H | 1 |
Vincenzi, B | 1 |
Badalamenti, G | 1 |
Armento, G | 1 |
Silletta, M | 1 |
Spalato Ceruso, M | 1 |
Catania, G | 1 |
Napolitano, A | 1 |
Maltese, G | 1 |
Valeri, S | 1 |
Incorvaia, L | 1 |
Santini, D | 1 |
Tonini, G | 1 |
2 other studies available for ifosfamide and Sarcopenia
Article | Year |
---|---|
Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Cispl | 2018 |
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents, Alkylating; Antineoplastic Co | 2018 |